Skip to main content
158 search results for:

Other comorbidities 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 16-11-2022 | ACR 2022 | Conference coverage | Article

    JUVE-BASIS: Support for baricitinib in juvenile arthritis

    Overall, the JUVE-BASIS results “support baricitinib as a treatment for signs and symptoms of JIA,” said Ramanan, noting that its oral route of administration is “more palatable to the children and families of children with juvenile arthritis” than other treatment options. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ACR Convergence 2022; Philadelphia, Pennsylvania, USA: November 10–14

  2. 14-10-2022 | Systemic sclerosis | News | Article

    Men may have a more severe SSc-ILD disease course than women

    On the other hand, there was a significant difference in the FVC response to cyclophosphamide by sex in the SLS II trial.

  3. 04-10-2022 | Systemic sclerosis | News | Article

    Elevated risk for osteoporotic fractures in women with SSc

    Older age (odds ratio [OR]=1.04) and female sex (OR=3.05) were identified as significant predictors of osteoporosis risk on univariable analysis, as were low BMI, prior falls, SSc duration, glucocorticoid use, and comorbidities.

  4. 06-10-2022 | Gout | News | Article
    News in brief

    SGLT2 inhibitors linked to lower gout risk than DPP-4 inhibitors

    After propensity score matching, the 16,144 people treated with SGLT2 inhibitors had a significantly lower risk for developing gout than the same number of matched individuals on DPP-4 inhibitors, with a hazard ratio (HR) of 0.49 after adjustment for factors including comorbidities, medications, and glycemic control.

  5. 15-09-2022 | Rheumatoid arthritis | Adis Journal Club | Article
    Drugs & Aging

    Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients

    Age-related conditions can lead to patients classified as difficult to treat, owing to the need for frequent treatment changes in response to comorbidities or adverse effects.

  6. 25-08-2022 | COVID-19 | News | Article

    ‘Substantial improvement’ in COVID-19 outcomes over time for RMD patients

    They caution, however, that some RMD patients “continue to experience severe disease, especially those on immunosuppressives known to blunt the response to vaccine and infection, as well as those with other serious comorbidities.”

  7. 11-07-2022 | Psoriatic arthritis | News | Article
    guidelinesWatch

    GRAPPA issues updated PsA treatment guidelines

    The recommendations also cover comorbidities with a potential influence on treatment, which are categorized into PsA-related conditions (inflammatory bowel disease [IBD] and uveitis) and other comorbidities.

  8. 17-06-2022 | Psoriasis | Adis Journal Club | Article
    Rheumatology and Therapy

    Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study

    Other characteristics found were: a “comorbidities trend” in LOP patients and a more frequent use of anti-IL17 in EOP.

  9. 04-06-2022 | EULAR 2022 | Conference coverage | Article

    Mixed results for MACE risk with JAK inhibitors in RA

    They also had a higher degree of functional impairment on average (63% of full physical function vs 69–72%) and a higher mean number of comorbidities (2.9 vs 2.2–2.6).

  10. 02-06-2022 | EULAR 2022 | Conference coverage | Article

    Topical alkalinizing treatment shows potential for acute gout

    Khanna pointed out the significance of a reduction in rescue medication use, which she said “is critical for patients who have concomitant comorbidities and also have kidney disease and want to minimize use of systemic therapies.”

  11. 03-06-2022 | EULAR 2022 | Conference coverage | Article

    Chronic, low-dose glucocorticoid benefits outweigh harms in senior patients with RA

    They suggest that “the risks of low-dose GC are not of special concern but should be viewed through the same lens as those of other DMARDs.”

  12. 09-05-2022 | Spondyloarthropathies | News | Article

    Psoriasis may impact clinical course of peripheral spondyloarthritis

    “On the other hand, there are currently no approved treatment options for patients with pSpA without a personal or family history of psoriasis and no evidence of axial involvement,” they write.

  13. 11-04-2022 | Rheumatoid arthritis | News | Article

    Biologic choice has minimal impact on acute coronary syndrome risk in RA

    They add: “Patients on abatacept and rituximab had more comorbidities and longer disease duration with potentially longer exposure to inflammation, which is associated with CV risk.”

  14. 16-08-2021 | Temporal cell arteritis | Teaser

    New additions to the Adis Journal Club

    A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

  15. 08-02-2022 | Temporal cell arteritis | Teaser

    Rituximab and rheumatology practice in the COVID-19 era

    How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

  16. 18-11-2021 | Rheumatoid arthritis | News | Article

    Excess mortality gap closing, but not for all rheumatic diseases

    “Given that effective therapeutic options and treat-to-target strategies, including control of comorbidities, can explain the improved survival observed in rheumatoid arthritis and the spondylarthritides during the calendar years 2015–2019, similar approaches should be implemented in all systemic rheumatic diseases,” they write.

  17. 02-12-2021 | COVID-19 | News | Article
    News in brief

    COVID-19: Meta-analysis suggests increased infection, mortality risk in people with RMDs

    The risk for mortality was also significantly elevated in RMD patients, at a pooled RR of 1.74, but other measures of COVID-19 severity, such as rates of hospitalization and mechanical ventilation, did not significantly differ in the two groups.

  18. 07-11-2021 | ACR 2021 | Conference coverage | Article

    High rates of severe COVID-19 in patients with vasculitis, polymyalgia rheumatica

    The most common diagnosis was PMR (31.1%), followed by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (29.4%), giant cell arteritis (15.2%), other vasculitis (15.0%), and Behçet’s syndrome (9.3%).

  19. 28-10-2021 | Juvenile idiopathic arthritis | News | Article

    Rates of comorbidities in JIA similar across large registries

    An analysis of data from three juvenile idiopathic arthritis registries shows “relatively similar” rates of comorbidities among JIA patients, say researchers who believe the finding highlights the potential for the registries to be used for synchronized analyses and harmonized collaborations.

  20. 06-11-2021 | ACR 2021 | Conference coverage | Article

    Observational data show patterns of neurologic, ocular manifestations in ANCA-associated vasculitis

    Hajj-Ali concluded that the data “should raise the awareness of this common manifestation of vasculitis,” adding that “[t]he relationships of neurologic involvement with other specific manifestations of disease warrants additional study.”

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.